Two Immune Cell Armies in One Infusion: Combination NK and T Cell Therapy Shows Promise in Hard-to-Treat Tumors
A phase 1 trial found that an autologous combination of natural killer cells and tumor-primed T lymphocytes was safe and ...
A phase 1 trial found that an autologous combination of natural killer cells and tumor-primed T lymphocytes was safe and ...
New research reveals how the tumor protein TIPE drives colorectal cancer progression by converting macrophages into tumor-supporting M2 cells through ...
A new review details how the CD47 don't eat me signal regulates efferocytosis and shapes disease outcomes in cancer, atherosclerosis ...
Researchers engineered an anti-C4d antibody that targets complement fragments left on tumor cells that survived antibody therapy, boosting complement-mediated killing ...
A new review in Advanced Composites and Hybrid Materials presents virus-like particles as adaptable biohybrid nanomaterials uniting established vaccines with ...
A new review explains how gut microbes program immunosuppressive regulatory B cells through cytokine and metabolite signals, with major implications ...
A pan-cancer single-cell epigenetic study reveals that tumor-supportive macrophages arise through distinct enhancer-driven trajectories in which releasing paused RNA polymerase ...
Using patient-derived hepatocellular carcinoma organoids, researchers identified mITGB2, a splice-variant-derived peptide presented by MHC class II, as a functionally immunogenic ...
A new review charts how mRNA, peptide, cell, and virus-based therapeutic vaccines, supercharged by AI-driven neoantigen prediction and combination immunotherapy, ...
Researchers have identified a bone marrow-derived CD11c-positive B220-positive NK cell subset selectively expanded by IL-15 that outperforms conventional NK cells ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine